Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lawsuit demands HHS Secretary Becerra follow federal law and add COVID vaccine to Vaccine Injury Compensation Program (VICP)


News provided by

mctlaw

Jan 17, 2025, 16:31 ET

Share this article

Share toX

Share this article

Share toX


A federal lawsuit filed this week alleges that the Secretary of Health and Human Services (HHS) has failed to meet the deadline required by federal law to include the COVID-19 vaccine in the National Vaccine Injury Compensation Program (VICP). The suit seeks to compel the HHS Secretary to comply with federal law and provide a legal mechanism to compensate vaccine injured people.

WASHINGTON, Jan. 17, 2025 /PRNewswire-PRWeb/ -- A federal lawsuit filed today alleges that the Secretary of Health and Human Services (HHS) has failed to meet the deadline required by federal law to include the COVID-19 vaccine in the National Vaccine Injury Compensation Program (VICP). The lawsuit was filed in Federal District Court for the District of Columbia on behalf of Paul Brundage. Mr. Brundage suffered a severe blood-clotting disorder after getting a COVID-19 vaccination (Case No: 25-119). The suit seeks to compel the HHS Secretary to comply with federal law and provide a legal mechanism to compensate vaccine injured people.

The lawsuit alleges Secretary Xavier Becerra failed to amend the Vaccine Injury Table as required by federal law within two years of the Centers for Disease Control (CDC) recommending the COVID-19 vaccine for routine administration to those age 18 and under. Until the COVID vaccine is covered by the VICP, people like Mr. Brundage cannot seek payment of medical expenses, lost wages, pain and suffering, and other compensation granted by the Vaccine Act.

"The only option right now for people injured by the COVID vaccine is the CICP, which for most is worse than nothing," says Altom Maglio, the attorney representing Mr. Brundage in the citizen suit.

Post this

After the Secretary adds the COVID vaccine to the Vaccine Injury Table, Congress will then need to authorize a payment of 75-cents from vaccine manufacturers to the VICP for each future COVID vaccine dose sold. Once Congress authorizes the 75-cent payment, Americans who have suffered severe COVID adverse vaccine reactions will be eligible to seek compensation from the Vaccine Injury Compensation Program, or VICP.

Although similar sounding in name to the VICP, the Countermeasures Injury Compensation Program (CICP) is presently the only source of compensation for COVID vaccine injuries. The complaint points out that the CICP provides no real recourse or compensation to people suffering serious COVID vaccine injuries.

According to data complied by HHS, 13,555 people in the United States have filed compensation claims in the CICP for severe injuries caused by the COVID vaccine, as of December 1, 2024. Only 20 out of more than 13-thousand have been awarded compensation. The average award to these people for their severe injuries is approximately $4-thousand dollars each, with the exception of compensation in one death case.

Vaccine adverse reaction claims under the VICP are brought in the United States Court of Federal Claims, a federal court of national jurisdiction. In contrast, CICP claims never see a courtroom or judge. Instead, they are decided in a secretive internal process by HHS.

"We have so far failed to honor our obligation to those Americans seriously injured by adverse reactions to the COVID vaccine," says Anne Toale, an mctlaw partner who has represented clients in the VICP for over two decades. "The Secretary needs to immediately comply with federal law and add the COVID vaccine to the Vaccine Injury Table, Congress must authorize the 75-cent payment, and then we can compensate these people for their injuries."

"The only option right now for people injured by the COVID vaccine is the CICP, which for most is worse than nothing," says Altom Maglio, the mctlaw attorney representing Mr. Brundage in the citizen suit. "The sooner the COVID vaccine is covered by the VICP, the sooner we can work to get injured folks their medical expenses, lost wages, and other money they urgently need."

For more information visit https://www.mctlaw.com/vaccine-injury/

Media Contact

Gilda Dennis, mctlaw, 1 (941) 879-9913, [email protected], https://www.mctlaw.com

SOURCE mctlaw

Modal title

Copy of the complaint filed against Sec. Becerra to add COVID vaccine injuries to the VICP
View PDF
Copy of the complaint filed against Sec. Becerra to add COVID vaccine injuries to the VICP
Copy of the complaint filed against Sec. Becerra to add COVID vaccine injuries to the VICP

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.